CORTECHS LABS
CorTechs Labs is a developer of a brain image analysis software used to offer better clinical insight through quantitative imaging. It develops and markets cutting-edge brain imaging solutions that are used by neurologists and radiologists in hundreds of clinics and research centers around the world. Its software acts as a convenient and cost-effective means to quantify brain structures that enable doctors in their assessment of a variety of neurological conditions, such as Alzheimer's disease, multiple sclerosis, epilepsy, and traumatic brain injury.
CORTECHS LABS
Industry:
Biotechnology Health Care Medical Device Software
Founded:
2001-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.cortechs.ai
Total Employee:
11+
Status:
Active
Contact:
8584599705
Email Addresses:
[email protected]
Total Funding:
1.97 M USD
Technology used in webpage:
SPF Apple Mobile Web Clips Icon Mobile Non Scaleable Content Microsoft Exchange Online Amazon Office 365 Mail Google Apps For Business GoDaddy DNS BootstrapCDN ASP.NET
Similar Organizations
EyeNetra
EyeNetra is a developer of an eye diagnostics platform used to measure the correction of users' vision through smartphone-based technology.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2020-06-12 | HealthLytix | HealthLytix acquired by CorTechs Labs | N/A |
Investors List
Dragasac Limited
Dragasac Limited investment in Series B - CorTechs Labs
Official Site Inspections
http://www.cortechs.ai Semrush global rank: 5.1 M Semrush visits lastest month: 1.6 K
- Host name: 155.195.231.35.bc.googleusercontent.com
- IP address: 35.231.195.155
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York

More informations about "CorTechs Labs"
Cortechs.ai - Crunchbase Company Profile & Funding
Cortechs.ai is a developer of brain image analysis software used to offer better clinical insight through quantitative imaging. It develops and markets cutting-edge brain imaging solutions that are used by neurologists and radiologists in โฆSee details»
Cortechs.ai Company Profile 2024: Valuation, Funding โฆ
Cortechs.ai General Information Description. Developer of brain image analysis software designed to offer better clinical insight through quantitative imaging. The company's software acts as a convenient and cost-effective means to quantify โฆSee details»
About - Cortechs.ai
At Cortechs.ai, our mission is to improve patient care by empowering physicians and clinicians with AI solutions to better detect, diagnose, and treat diseases. By merging state-of-the-art medical imaging with the power of machine learning โฆSee details»
Cortechs.ai - LinkedIn
Cortechs.ai's flagship product, NeuroQuant®, is a breakthrough, 510(k) cleared medical device that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice ...See details»
Cortechs.ai - Funding, Financials, Valuation & Investors - Crunchbase
Cortechs.ai has acquired HealthLytix on Jun 12, 2020. Which types of acquisition does this organization make most frequently? Show . Acquiree Name . Announced Date . Price . โฆSee details»
Cortechs - Crunchbase Company Profile & Funding
Sdbn.org โ Cortechs.ai Receives FDA 510(k) Clearance for Groundbreaking NeuroQuant 5.0 Software, Expanding Support for Quantification of ARIA-E and ARIA-H Funding Round โข Oct 22, 2018 Cortechs raised โฌ1,300,000 / Grant โฆSee details»
Cortechs.ai Appoints Kyle Frye as New Chief Executive โฆ
Apr 3, 2024 San Diego, CA โ Cortechs.ai, a leading innovator in AI applications for radiology and the developer of FDA-cleared products for the improved detection of neurodegenerative diseases and cancer, is excited to announce โฆSee details»
Cortechs.ai Announces Oversubscribed Funding Round to โฆ
Nov 20, 2024 Cortechs.ai, a leader in AI-powered neuroimaging and prostate imaging solutions, is pleased to announce the successful close of an oversubscribed Series C funding round led โฆSee details»
Cortechs.ai Announces Oversubscribed Funding Round to โฆ
SAN DIEGO, Nov. 20, 2024 /PRNewswire/ -- Cortechs.ai, a leader in AI-powered neuroimaging and prostate imaging solutions, is pleased to announce the successful close of an โฆSee details»
Cortechs.ai Welcomes Kyle Frye As CEO To Advance AI โฆ
Apr 3, 2024 Cortechs.ai, a pioneer in AI for radiology, has named Kyle Frye its new CEO, aiming to further their lead in detecting neurodegenerative diseases and cancer. ... "I am honored to be joining a growing organization that is โฆSee details»
Cortechs.ai Awarded Million Dollar NIH Grant for Early Diagnosis โฆ
Aug 29, 2022 The National Institute of Health awards Cortechs.ai a multimillion grant to quantify microstructural changes in Alzheimer's Disease using Restriction Spectrum Imaging.SAN โฆSee details»
Cortechs.ai Highlights Groundbreaking NeuroQuant® ARIA โฆ
Nov 14, 2024 Cortechs.ai is the only organization capable of processing both GRE and SWI sequencesโsetting a new standard for comprehensive and reliable imaging solutions. This โฆSee details»
Cortechs.ai Partners with Mermaid Beach Radiology to Bring โฆ
6 days ago The integration of Cortechs.ai's software into Mermaid Beach Radiology's practice underscores the growing global shift toward AI-driven healthcare solutions, setting a new โฆSee details»
Contact - Cortechs.ai
Connect with our sales team to discover how Cortechs.ai can empower your organization. Book a demo. ... Fill out this form and a relevant Cortechs.ai representative will get back to you. If you โฆSee details»
Cortechs.ai - Contacts, Employees, Board Members, Advisors
Cortechs.ai develops and markets imaging solutions that are used by radiologists, neurologists, and oncologists.See details»
Cortechs.ai Receives FDA 510 (k) Clearance for Groundbreaking ...
Sep 3, 2024 "Receiving FDA clearance for NeuroQuant® 5.0 is a testament to Cortechs.ai's relentless drive to innovate and lead the industry in imaging-based AI technologies," said Kyle โฆSee details»
Invest In Cortechs.ai Stock | Buy Pre-IPO Shares | EquityZen
Nov 21, 2024 Cortechs.ai is a developer of brain image analysis software used to offer better clinical insight through quantitative imaging. It develops and markets cutting-edge brain โฆSee details»
Paris dreams of becoming the capital of positive AI with the ...
1 day ago After the Olympic Games, artificial intelligence (AI)? Paris intends to attract global attention once again with the Summit for Action on AI, to be held at the Grand Palais. On โฆSee details»
Cloud Login - Cortechs.ai
Access your organizationโs Cortechs.ai user account. v3 Users Choose your region below to access your Cortechs.ai v3 account. Americas Europe Asia, Africa, Oceania Our solutions. โฆSee details»
Insights - Cortechs.ai
Cortechs.ai Announces Major FDA 510(k)-Pending Update to NeuroQuant Software . The latest update to NeuroQuant® will expand the use of the software to support identification and โฆSee details»